All Relations between Schizophrenia and Aripiprazole

Publication Sentence Publish Date Extraction Date Species
b' Suzana Uzun, Oliver Kozumplik, Biserka Sedi\\xc4\\x8. Changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - Case report. Psychiatria Danubina. vol 22. issue 2. 2010-08-27. PMID:20562787.' changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - case report. 2010-08-27 2023-08-12 Not clear
b' Suzana Uzun, Oliver Kozumplik, Biserka Sedi\\xc4\\x8. Changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - Case report. Psychiatria Danubina. vol 22. issue 2. 2010-08-27. PMID:20562787.' the aim of this article is to report a case of changes in values of cholesterol and tryglicerides after weight loss, during treatment with aripiprazole in a patient with schizophrenia. 2010-08-27 2023-08-12 Not clear
I Normala, A Hamidi. The use of aripiprazole in early onset schizophrenia: safety and efficacy. The Medical journal of Malaysia. vol 64. issue 3. 2010-08-13. PMID:20527278. the use of aripiprazole in early onset schizophrenia: safety and efficacy. 2010-08-13 2023-08-12 Not clear
Chi-Un Pae, Alberto Chiesa, Alessandro Serrett. Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. Psychiatry research. vol 178. issue 2. 2010-08-12. PMID:20471098. we investigated possible influences of 3 single nucleotide polymorphisms in the d-amino acid oxidase activator (rs2391191, rs947267, rs3918342) on clinical outcomes and side effects in 86 korean schizophrenia patients treated with aripiprazole for 8weeks, finding that individuals carrying rs2391191 a allele had significantly lower brief psychiatric rating scale scores than subjects carrying the g allele at each time point. 2010-08-12 2023-08-12 human
Hiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Haruo Kashim. Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study. Psychiatry and clinical neurosciences. vol 64. issue 1. 2010-07-15. PMID:19968829. changes in metabolic parameters following a switch to aripiprazole in japanese patients with schizophrenia: one-year follow-up study. 2010-07-15 2023-08-12 Not clear
Hiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Haruo Kashim. Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study. Psychiatry and clinical neurosciences. vol 64. issue 1. 2010-07-15. PMID:19968829. in this 1-year observation study, following a switch to aripiprazole, 32 patients with schizophrenia were observed and assessment was done of bodyweight, total cholesterol, triglyceride, serum prolactin level, and corrected qt (qtc) interval. 2010-07-15 2023-08-12 Not clear
Hwa-Young Lee, Byung-Joo Ham, Rhee-Hun Kang, Jong-Woo Paik, Sang-Woo Hahn, Moon-Soo Lee, Min-Soo Le. Trial of aripiprazole in the treatment of first-episode schizophrenia. Psychiatry and clinical neurosciences. vol 64. issue 1. 2010-07-15. PMID:20416024. trial of aripiprazole in the treatment of first-episode schizophrenia. 2010-07-15 2023-08-12 Not clear
Hwa-Young Lee, Byung-Joo Ham, Rhee-Hun Kang, Jong-Woo Paik, Sang-Woo Hahn, Moon-Soo Lee, Min-Soo Le. Trial of aripiprazole in the treatment of first-episode schizophrenia. Psychiatry and clinical neurosciences. vol 64. issue 1. 2010-07-15. PMID:20416024. aripiprazole is an atypical antipsychotic indicated for the treatment of adult patients with schizophrenia. 2010-07-15 2023-08-12 Not clear
Hwa-Young Lee, Byung-Joo Ham, Rhee-Hun Kang, Jong-Woo Paik, Sang-Woo Hahn, Moon-Soo Lee, Min-Soo Le. Trial of aripiprazole in the treatment of first-episode schizophrenia. Psychiatry and clinical neurosciences. vol 64. issue 1. 2010-07-15. PMID:20416024. the aim of the present study was to investigate therapeutic efficacy and tolerability of aripiprazole in patients with first-episode schizophrenia. 2010-07-15 2023-08-12 Not clear
Junya Fujino, Hideki Tanaka, Norio Taniguchi, Kaoru Tabush. Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia. Psychiatry and clinical neurosciences. vol 64. issue 1. 2010-07-15. PMID:20416032. effectiveness of aripiprazole in a patient with presumed idiopathic parkinson's disease and chronic paranoid schizophrenia. 2010-07-15 2023-08-12 Not clear
Florian Schlagenhauf, Martin Dinges, Anne Beck, Torsten Wüstenberg, Eva Friedel, Theresa Dembler, Rahul Sarkar, Jana Wrase, Jürgen Gallinat, Georg Juckel, Andreas Hein. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. Schizophrenia research. vol 118. issue 1-3. 2010-07-13. PMID:20189356. switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. 2010-07-13 2023-08-12 Not clear
Janelle Guirguis-Blak. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia. American family physician. vol 81. issue 11. 2010-06-22. PMID:20521753. aripiprazole vs. other atypical antipsychotics for schizophrenia. 2010-06-22 2023-08-12 Not clear
Thomas Messer, Max Schmauss, Terez Spevakne-Goeroecs, Martin Kungel, Marcel Ebrecht, Christian Werner, Sieglinde Model. Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 11. issue 2 Pt 2. 2010-06-14. PMID:20218786. clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the german postmarketing surveillance study. 2010-06-14 2023-08-12 Not clear
Thomas Messer, Max Schmauss, Terez Spevakne-Goeroecs, Martin Kungel, Marcel Ebrecht, Christian Werner, Sieglinde Model. Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 11. issue 2 Pt 2. 2010-06-14. PMID:20218786. the results demonstrate that the administration of aripiprazole can result in an improvement of the symptoms of schizophrenia within 4 weeks in a real-life hospital-based in- and outpatient setting. 2010-06-14 2023-08-12 Not clear
M Riedel, I Spellmann, R Schennach-Wolff, R Musil, S Dehning, A Cerovecki, M Opgen-Rhein, J Matz, F Seemüller, M Obermeier, E Severus, R R Engel, N Müller, H-J Mölle. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. Pharmacopsychiatry. vol 43. issue 2. 2010-06-11. PMID:20336597. effect of aripiprazole on cognition in the treatment of patients with schizophrenia. 2010-06-11 2023-08-12 Not clear
M Riedel, I Spellmann, R Schennach-Wolff, R Musil, S Dehning, A Cerovecki, M Opgen-Rhein, J Matz, F Seemüller, M Obermeier, E Severus, R R Engel, N Müller, H-J Mölle. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. Pharmacopsychiatry. vol 43. issue 2. 2010-06-11. PMID:20336597. the aim of this study was to assess the cognitive effects of aripiprazole in inpatients with schizophrenia. 2010-06-11 2023-08-12 Not clear
Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Jeong-Hoon Lee, Yo-Han Lee, Su-Jin Yang, Jin-Sang Yoo. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. Clinical neuropharmacology. vol 32. issue 5. 2010-06-01. PMID:19620849. effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. 2010-06-01 2023-08-12 Not clear
Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Jeong-Hoon Lee, Yo-Han Lee, Su-Jin Yang, Jin-Sang Yoo. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. Clinical neuropharmacology. vol 32. issue 5. 2010-06-01. PMID:19620849. to examine changes in cognitive function and clinical features after a switch from atypical antipsychotics to aripiprazole in patients with schizophrenia. 2010-06-01 2023-08-12 Not clear
Taro Kishi, Masatsugu Moriwaki, Tsuyoshi Kitajima, Kunihiro Kawashima, Tomo Okochi, Yasuhisa Fukuo, Osamu Furukawa, Hiroshi Naitoh, Kiyoshi Fujita, Nakao Iwat. Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia. Psychopharmacology. vol 209. issue 2. 2010-05-28. PMID:20177883. effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in japanese chronic schizophrenia. 2010-05-28 2023-08-12 Not clear
Taro Kishi, Masatsugu Moriwaki, Tsuyoshi Kitajima, Kunihiro Kawashima, Tomo Okochi, Yasuhisa Fukuo, Osamu Furukawa, Hiroshi Naitoh, Kiyoshi Fujita, Nakao Iwat. Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia. Psychopharmacology. vol 209. issue 2. 2010-05-28. PMID:20177883. we investigated the influence on startle response in chronic schizophrenia in 20 patients with schizophrenia taking risperidone, 21 patients with schizophrenia taking olanzapine, and 20 patients with schizophrenia taking aripiprazole. 2010-05-28 2023-08-12 Not clear